System and method for high-yield transient expression in mammalian cells
High-yield mammalian transient expression systems can include a cell culture media (particularly serum free, non-animal derived, and/or chemically defined media) for introducing macromolecules and compounds (e.g., nucleic acid molecules) into cells (e.g., eukaryotic cells). Cells containing such introduced materials can then be cultured in the cell culture media. In particular, the invention allows introduction of nucleic acid molecules (e.g., vectors) into cells (particularly mammalian cells) and expression of proteins encoded by the nucleic acid molecules in the cells. The invention obviates the need to change the cell culture medium each time a different procedure is performed with the cells (e.g., culturing cells vs. transfecting cells). The invention also relates to compositions and kits useful for culturing and transforming/transfecting cells.
1. A transient expression system comprising:
a. suspension 293 cells, wherein said suspension 293 cells have been adapted for growth under high density conditions of greater than 2×10 6 cells/ml;
b. high density culture medium;
c. a transfection reagent comprising a cationic lipid; and
d. two or more expression enhancers comprising valproic acid (VPA) or a salt thereof and sodium propionate.
2. The expression system according to claim 1 , wherein said suspension 293 cells are adapted for improved growth and viability characteristics and improved recombinant protein expression under high density culture conditions compared to the cell line from which they are obtained.
3. The expression system according to claim 1 , wherein said two or more expression enhancers further comprise one or more of lithium acetate (LiAc), dimethyl sulfoxide (DMSO), galactose, butyric acid, or any salts thereof.
4. The expression system according to claim 3 , wherein said two or more expression enhancers comprise LiAc or galactose, or combinations thereof.
5. The expression system according to claim 3 , wherein said LiAc is provided in sufficient quantity to achieve a final concentration during use in a range of 0.25 to 25 mM.
6. The expression system according to claim 5 , wherein the concentration of LiAc is in a range of 0.26 mM to 20 mM.
7. The expression system according to claim 1 , wherein said suspension 293 cells are obtained from 293 cells, 293F cells, or obtained from 293F cells.
8. The expression system according to claim 1 , wherein said high density culture medium is a serum-free/protein-free chemically defined culture medium.
9. The expression system according to claim 1 , wherein said high density culture medium is capable of promoting the growth of transfected 293 cells at densities in excess of 2.5×10 6 cells/ml with a cell viability remaining in excess of 80%.
10. The expression system according to claim 1 , wherein said high density culture medium can support said suspension 293 cells at a density of between 2×10 6 to 2×10 7 cells/ml.
11. The expression system according to claim 1 , wherein said sodium propionate is provided in sufficient quantity to achieve a final concentration during use in the range of 0.2 mM to 100 mM.
12. The expression system according to claim 11 , wherein the concentration of sodium propionate is in a range of 0.5 to 80 mM.
13. The expression system according to claim 12 , wherein the concentration of sodium propionate is in a range of 0.6 mM to 50 mM.
14. The expression system according to claim 1 , wherein said VPA is provided in sufficient quantity to achieve a final concentration during use in the range of 0.20 mM to 25 mM.
15. The expression system according to claim 14 , wherein the concentration of VPA is in a range of 0.25 mM to 24 mM.
16. The expression system according to claim 15 , wherein the concentration of VPA is in a range of 0.44 mM to 10 mM.
17. The expression system according to claim 1 , further comprising an expressible nucleic acid comprising an expression vector containing a genetic sequence capable of producing an expressed protein.
18. The expression system according to claim 17 , wherein said expression vector comprises a woodchuck hepatitis virus posttranscriptional regulatory element (WPRE).